3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Specimen Handling
441
Magnetic Resonance Spectroscopy
340
pembrolizumab
286
Biopsy
242
Carboplatin
228
Cisplatin
193
Cyclophosphamide
177
Paclitaxel
160
Nivolumab
152
Gemcitabine
147
Bevacizumab
123
Radiotherapy
120
Dexamethasone
110
Pemetrexed
101
fludarabine
95
Fluorouracil
95
atezolizumab
90
Radiation
90
venetoclax
89
Docetaxel
88
Doxorubicin
86
Oxaliplatin
85
durvalumab
84
Rituximab
83
Leucovorin
81
Capecitabine
75
Prednisone
72
Lenalidomide
69
X-Rays
67
Etoposide
67
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hizentra
×
30 days
×
Clear all
NCT07582432
2026-05-12
SIGMA
Grifols Biologicals, LLC
Phase 3
Recruiting
49 enrolled